Sinuva

Active Ingredient(s): Mometasone Furoate
FDA Approved: * December 8, 2017
Pharm Company: * INTERSECT ENT INC
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Sinuva Overview

Mometasone furoate is a glucocorticoid or corticosteroid used topically to reduce inflammation of the skin or in the airways. It is a prodrug of the free form mometasone (INN).[citation needed] Contents 1 Medical uses 1.1 Asthma 2 Pharmacology 2.1 Pharmacodynamics 2.1.1 Mechanism of action 2.2 Pharmacokinetics 2.2.1 Metabolism 3 Society and culture 3.1 Brand names 4 References Medical uses Mometasone furoate is used in the treatment of inflammatory skin...

Read more Sinuva Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mometasone_furoate

Recent Sinuva Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Mometasone Furoate
  • Cream: 0.1%, 0.10%
  • Implant: 1.35mg
  • Inhalant: 220mcg/actuation
  • Lotion: 0.1%, 0.10%
  • Ointment: 0.1%, 0.10%
  • Powder: 0.11mg/inh, 0.22mg/inh
  • Solution: 0.1%
  • Spray, Metered: 0.05mg/spray, 50mcg/actuation
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sinuva: (1 result)

Sorted by National Drug Code
  • 10599-003 Sinuva 1350 ug/1 Intrasinal Implant by Intersect Ent, Inc.

Other drugs which contain Mometasone Furoate or a similar ingredient: (7 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 October 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 501 S. Cherry St, Suite 1100, Denver, CO, 80246, USA